Our analysis shows that venturing rounds at most stages have grown their median dollar size. Later-stage rounds have experienced a much more pronounced growth.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

GV has contributed to a $92m series B round for Tenaya, three years after it was spun out of Gladstone Institutes and University of Texas Southwestern Medical Center.

Livzon Pharmaceutical Group has been identified as an investor by MIT spinout Elicio Therapeutics, which just completed a series B round that takes its total financing to $63m.

GV has contributed to a $92m series B for Tenaya, three years after it was spun out of Gladstone Institutes and University of Texas Southwestern Medical Center.

Livzon Pharmaceutical Group has been identified as an investor by Elicio Therapeutics, which just completed a series B round that takes its total financing to $63m.

Samsung, OCI, Regeneron, Handok, Johnson & Johnson and existing investor Novartis all took part in the cell therapy developer's latest round.

Samsung Next and Commerzbank’s Main Incubator vehicle reinvested as part of the $12m equity portion of a $44.7m debt and equity round.

The passwordless access technology developer has closed an $18.3m round led by Comcast Ventures that included Samsung Next and existing backer Mastercard.

The Slack-backed startup has launched its presentation platform in beta and secured $30m to take its overall funding to more than $52m.